| 98.02 |  +0.06 / +0.06% |
Data as of 4:01pm ET | Day’s Change |
| 98.02 |  0.00 / 0.00% |
Volume: 4.7K |
| 4 Stocks Going Ex-Dividend Tomorrow: PGH, NTI, MAT, AGN May 20 / TheStreet.com | Allergan Stock To Go Ex-dividend Tomorrow (AGN) May 20 / TheStreet.com |
| Previous close | 97.96 |
| Today’s open | 97.58 |
| Day’s range | 96.88 - 98.57 |
| Volume | 1,833,769 |
| Average volume (3 months) | 1,864,082 |
| Market cap | $29.0B |
| Dividend yield | 0.20% |
| Earnings growth (last year) | +18.94% |
| Earnings growth (this year) | +14.76% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +8.58% |
| P/E ratio | 26.3 |
| Price/Sales | 4.76 |
| Price/Book | 5.04 |
| Today’s change | Today’s % change | |
|---|---|---|
| VRXValeant Pharmaceutic... | +9.80 | +13.12% |
| ALXNAlexion Pharmaceutic... | -0.71 | -0.71% |
| SHPGShire PLC | +2.75 | +2.84% |
| VRTXVertex Pharmaceutica... | -0.08 | -0.10% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $1.20 |
| Annual revenue (last year) | $5.8B |
| Annual profit (last year) | $1.1B |
| Net profit margin | 18.92% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer David E. I. Pyott, MBA |
Chief Financial Officer & EVP-Business Development Jeffrey L. Edwards |
Corporate headquarters Irvine, California |
.
